Technical Analysis for ARYX - Aryx Therapeutics

Grade Last Price % Change Price Change
grade D 0.0018 -43.75% -0.0014
ARYX closed down 43.75 percent on Thursday, January 23, 2020, on 2 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ARYX trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Crossed Above 200 DMA Bullish -43.75%
Crossed Above 20 DMA Bullish -43.75%
Crossed Above 50 DMA Bullish -43.75%
Pocket Pivot Bullish Swing Setup -43.75%
Older signals for ARYX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of oral therapies for chronic disease. The Companys clinical compounds include naronapride (ATI-7505) for gastrointestinal disorders; budiodarone (ATI-2042, for the treatment of atrial fibrillation; tecarfarin (ATI-5923) for the treatment of anticoagulation; and ATI-9242, for psychiatric disorders.
Medicine Health RTT Health Sciences Immunology Antibodies Monoclonal Antibody Atrial Fibrillation Chronic Disease Psychiatric Disorders Anticoagulant Gastrointestinal Disorders Cardiac Arrhythmia Oral Therapies

Is ARYX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.02
52 Week Low 0.0011
Average Volume 20,034
200-Day Moving Average 0.0028
50-Day Moving Average 0.0019
20-Day Moving Average 0.0020
10-Day Moving Average 0.0025
Average True Range 0.0008
ADX 19.02
+DI 49.4624
-DI 43.0108
Chandelier Exit (Long, 3 ATRs ) 0.0012
Chandelier Exit (Short, 3 ATRs ) 0.0035
Upper Bollinger Band 0.0034
Lower Bollinger Band 0.0006
Percent B (%b) 0.43
BandWidth 140.0000
MACD Line 0.0001
MACD Signal Line -0.0001
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0018
Resistance 3 (R3) 0.0018 0.0018 0.0018
Resistance 2 (R2) 0.0018 0.0018 0.0018 0.0018
Resistance 1 (R1) 0.0018 0.0018 0.0018 0.0018 0.0018
Pivot Point 0.0018 0.0018 0.0018 0.0018 0.0018
Support 1 (S1) 0.0018 0.0018 0.0018 0.0018 0.0018
Support 2 (S2) 0.0018 0.0018 0.0018 0.0018
Support 3 (S3) 0.0018 0.0018 0.0018
Support 4 (S4) 0.0018